A Samsiah1,2, Noordin Othman3, Shazia Jamshed1, Mohamed Azmi Hassali4, W M Wan-Mohaina5. 1. Kuliyyah of Pharmacy, International Islamic University Malaysia, 25200, Kuantan, Pahang, Malaysia. 2. Institute for Health Systems Research, Ministry of Health, 40170, Shah Alam, Selangor, Malaysia. 3. Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University, Almadinah Almunawwarah, Saudi Arabia. noordin_uia@yahoo.com. 4. School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia. 5. Pharmaceutical Service Division, Ministry of Health, Petaling Jaya, 46350, Petaling Jaya, Selangor, Malaysia.
Abstract
PURPOSE: Reporting and analysing the data on medication errors (MEs) is important and contributes to a better understanding of the error-prone environment. This study aims to examine the characteristics of errors submitted to the National Medication Error Reporting System (MERS) in Malaysia. METHODS: A retrospective review of reports received from 1 January 2009 to 31 December 2012 was undertaken. Descriptive statistics method was applied. RESULTS: A total of 17,357 MEs reported were reviewed. The majority of errors were from public-funded hospitals. Near misses were classified in 86.3 % of the errors. The majority of errors (98.1 %) had no harmful effects on the patients. Prescribing contributed to more than three-quarters of the overall errors (76.1 %). Pharmacists detected and reported the majority of errors (92.1 %). Cases of erroneous dosage or strength of medicine (30.75 %) were the leading type of error, whilst cardiovascular (25.4 %) was the most common category of drug found. CONCLUSIONS: MERS provides rich information on the characteristics of reported MEs. Low contribution to reporting from healthcare facilities other than government hospitals and non-pharmacists requires further investigation. Thus, a feasible approach to promote MERS among healthcare providers in both public and private sectors needs to be formulated and strengthened. Preventive measures to minimise MEs should be directed to improve prescribing competency among the fallible prescribers identified.
PURPOSE: Reporting and analysing the data on medication errors (MEs) is important and contributes to a better understanding of the error-prone environment. This study aims to examine the characteristics of errors submitted to the National Medication Error Reporting System (MERS) in Malaysia. METHODS: A retrospective review of reports received from 1 January 2009 to 31 December 2012 was undertaken. Descriptive statistics method was applied. RESULTS: A total of 17,357 MEs reported were reviewed. The majority of errors were from public-funded hospitals. Near misses were classified in 86.3 % of the errors. The majority of errors (98.1 %) had no harmful effects on the patients. Prescribing contributed to more than three-quarters of the overall errors (76.1 %). Pharmacists detected and reported the majority of errors (92.1 %). Cases of erroneous dosage or strength of medicine (30.75 %) were the leading type of error, whilst cardiovascular (25.4 %) was the most common category of drug found. CONCLUSIONS:MERS provides rich information on the characteristics of reported MEs. Low contribution to reporting from healthcare facilities other than government hospitals and non-pharmacists requires further investigation. Thus, a feasible approach to promote MERS among healthcare providers in both public and private sectors needs to be formulated and strengthened. Preventive measures to minimise MEs should be directed to improve prescribing competency among the fallible prescribers identified.
Authors: Pascale Carayon; Tosha B Wetterneck; Randi Cartmill; Mary Ann Blosky; Roger Brown; Robert Kim; Sandeep Kukreja; Mark Johnson; Bonnie Paris; Kenneth E Wood; James Walker Journal: BMJ Qual Saf Date: 2013-09-19 Impact factor: 7.035
Authors: Merrilyn Walton; Helen Woodward; Samantha Van Staalduinen; C Lemer; F Greaves; D Noble; B Ellis; L Donaldson; B Barraclough Journal: Qual Saf Health Care Date: 2010-12
Authors: Johanna I Westbrook; Ling Li; Elin C Lehnbom; Melissa T Baysari; Jeffrey Braithwaite; Rosemary Burke; Chris Conn; Richard O Day Journal: Int J Qual Health Care Date: 2015-01-12 Impact factor: 2.038
Authors: Darren M Ashcroft; Penny J Lewis; Mary P Tully; Tracey M Farragher; David Taylor; Valerie Wass; Steven D Williams; Tim Dornan Journal: Drug Saf Date: 2015-09 Impact factor: 5.606